Bunkyo-ku

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Beeline Medicines Corporation1 trial
• Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Running trials

• Not yet recruiting

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· Phase 3· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

  Contact: Site 0117

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

  NCT04895696· Phase 2· Beeline Medicines Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Systemic sclerosis (scleroderma)1 recruiting